PHASE-I CLINICAL-TRIAL OF GEMCITABINE GIVEN AS AN INTRAVENOUS BOLUS ON 5 CONSECUTIVE DAYS

被引：45

作者：

OROURKE, TJ ^{[1
]}

BROWN, TD ^{[1
]}

HAVLIN, K ^{[1
]}

KUHN, JG ^{[1
]}

CRAIG, JB ^{[1
]}

BURRIS, HA ^{[1
]}

SATTERLEE, WG ^{[1
]}

TARASSOFF, PG ^{[1
]}

VONHOFF, DD ^{[1
]}

机构：

[1] BROOKE ARMY MED CTR,FT SAM HOUSTON,TX 78234

来源：

EUROPEAN JOURNAL OF CANCER | 1994年 / 30A卷 / 03期

关键词：

D O I：

10.1016/0959-8049(94)90276-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：417 / 419

页数：3

共 7 条

[1] A PHASE-I CLINICAL, PLASMA, AND CELLULAR PHARMACOLOGY STUDY OF GEMCITABINE [J].

ABBRUZZESE, JL ;

GRUNEWALD, R ;

WEEKS, EA ;

GRAVEL, D ;

ADAMS, T ;

NOWAK, B ;

MINEISHI, S ;

TARASSOFF, P ;

SATTERLEE, W ;

RABER, MN ;

PLUNKETT, W .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (03) :491-498

[2]

BROWN T, 1991, P AN M AM SOC CLIN, V10, P115

[3]

CLAVEL MD, 1989, P AN M AM SOC CLIN, V8, P79

[4]

ELIS J, 1970, CLIN PHARMACOL THER, V11, P404

[5]

HEIHEMANN V, 1988, CANCER RES, V48, P4024

[6]

HERTEL LW, 1990, CANCER RES, V50, P4417

[7]

POPLIN E, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P282

← 1 →